Table 1.
Patient’s number | EPR spectrum type | Gender W/M | Hb (mmol/l) 7.6–10.0 | Fe (μg/dl) W: 37–145 M: 61–157 |
Tf (g/l) 2.0–3.6 | TIBC (μg/dl) 240–480 | UIBC (μg/dl) 115–350 | Ferr (μg/l) W: 15–150 M: 30–400 |
Transferrin saturation (%) W: <50 M: <60 |
---|---|---|---|---|---|---|---|---|---|
1 | I | W | 7.7 | 54 | 3.1 | 354 | 300 | 16 | 15.3 |
2 | III | M | 10.4 | 101 | 2.8 | 324 | 223 | 76 | 31.2 |
3 | II | W | 8.0 | 86 | 3.0 | 331 | 245 | 30 | 25.9 |
4 | II | W | 8.9 | 86 | 3.0 | 337 | 251 | 65 | 25.5 |
5 | III | W | 8.9 | 88 | 3.0 | 336 | 248 | 49 | 26.2 |
6 | I | M | 9.8 | 118 | 2.9 | 349 | 231 | 103 | 33.8 |
7 | – | M | 8.6 | 86 | 2.7 | 316 | 230 | 248 | 27.2 |
8 | – | W | 9.4 | 74 | 2.3 | 270 | 196 | 64 | 27.4 |
9 | I | W | 7.6 | 45 | 2.6 | 329 | 284 | 112 | 13.7 |
10 | I | M | 9.6 | 106 | 2.8 | 336 | 230 | 175 | 31.6 |
11 | II | M | 10.1 | 80 | 2.3 | 290 | 210 | 90 | 27.6 |
12 | I | W | 8.9 | 89 | 3.0 | 365 | 276 | 75 | 24.4 |
13 | II | W | 7.9 | 59 | 3.0 | 384 | 325 | 81 | 15.4 |
14 | I | M | 8.8 | 59a | 3.1 | 398 | 339 | 166 | 14.8 |
15 | I | W | 8.6 | 104 | 2.9 | 368 | 264 | 142 | 28.3 |
16 | II | W | 8.1 | 79 | 2.4 | 284 | 205 | 137 | 27.8 |
17 | – | M | 9.9 | 142 | 2.5 | 330 | 188 | 240 | 43.0 |
18 | II | W | 8.3 | 78 | 2.6 | 327 | 249 | 40 | 23.9 |
19 | I | W | 8.2 | 83 | 3.2 | 389 | 306 | 35 | 21.3 |
20 | I | W | 8.1 | 185a | 2.7 | 324 | 157 | 35 | 54.1a |
Mean value | 8.8 | 90 | 2.8 | 338 | 248 | 99 | 26.9 |
Hb Hemoglobin concentration (mmol/l), Fe iron concentration (μg/dl), Tf transferrin concentration (g/l), TIBC total iron-binding capacity (μg/dl), UIBC unbound iron-binding capacity (μg/dl), Ferr ferritin concentration (μg/l), transferrin saturation (%), W woman, M man
aAbove or below the laboratory norm. For examples of the EPR spectrum types see Figs. 2 and 3